Next Article in Journal
Health, Economic and Social Development Challenges of the COVID-19 Pandemic: Strategies for Multiple and Interconnected Issues
Previous Article in Journal
Future Scenarios of the Data-Driven Healthcare Economy in South Korea
Previous Article in Special Issue
The Preventive Effect of Dysphagia Screening on Pneumonia in Acute Stroke Patients: A Systematic Review and Meta-Analysis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Analysis of Research Directions on the Rehabilitation of Patients with Stroke and Diabetes Using Scientometric Methods

1
Faculty of Medicine, Transilvania University of Brasov, 500036 Brasov, Romania
2
Faculty of Product Design and Environment, Transilvania University of Brasov, 500036 Brasov, Romania
3
Department of Fundamental Disciplines and Clinical Prevention, Transilvania University of Brasov, 500036 Brasov, Romania
*
Author to whom correspondence should be addressed.
Healthcare 2022, 10(5), 773; https://doi.org/10.3390/healthcare10050773
Submission received: 26 March 2022 / Revised: 16 April 2022 / Accepted: 18 April 2022 / Published: 21 April 2022
(This article belongs to the Special Issue Consequences of Stroke)

Abstract

:
The multidisciplinary approach to the rehabilitation of patients with stroke and diabetes has been followed in this article by a review of the literature published in the Web of Science in the last ten years. A review of the literature was performed using scientometric methods. VOS Viewer software was used to determine the research directions in this area. Scientometric analysis has extracted relevant published scientific output that treats diabetes and stroke. Studies based on qualitative research and the conclusions of these studies were analyzed. The clusters with the keywords used in the title and abstract by the authors who published in the Web of Science were reviewed and research directions in the field were formulated. The proper care of diabetes and its numerous consequences, including stroke and its neurologic complications, necessitates the fast identification of research findings in various types of medicines and their efficacy when applied to various patient groups, such as diabetic patients, whose recovery after a stroke is similar to that of a nondiabetic patient following hemodynamic stabilization, although it takes longer and has poorer outcomes. The limitations of the study refer to the fact that the data reviewed are from the Web of Science only.

1. Introduction

1.1. Multi-Perspective Approach

The multi-perspective approach involves exploring the challenges and opportunities involved in developing rigorous and coherent research methodologies to capture complex phenomena by using multiple perspectives to explore the same phenomenon [1]. This multi-perspective approach was designed to facilitate patient-centered design and evaluation. We used diabetes and stroke scientific production to analyze field observations, structured interviews, and document analysis to collect and analyze user workflow patterns, decision support goals, and diabetes patient interaction preferences.
The purpose of this meta-analysis using scientometric methods is to identify possible approaches to the recovery of post-stroke diabetic patients.
Although there are still ongoing studies to identify the particular approach of the diabetic patient in post-stroke recovery to date, no particular method has been identified for them compared to patients without diabetes. The only difference is the extension of the recovery period in diabetic versus non-diabetic patients.
Diabetes mellitus may influence the post-stroke clinical evolution, especially in the initial phase, increasing the extension of the cerebral injured area [2]. Few studies have been aimed at studying the influence of diabetes on functional outcomes after stroke, and their results are not conclusive [3].
Diabetes is a chronic disease with a growing prevalence that affected a population of approximately 415 million in 2015, and will reach approximately 642 million in 2040 [3]. Diabetes increases the risk of stroke four-fold.
Analyzing the literature shows that there are various implications that diabetes has on different patients. We present some situations that the authors in the field presented in their published articles:
-
For stroke, diabetes is an independent risk factor and is associated with increased mortality and morbidity [4].
-
In diabetic patients, there is a high proportion of ischemic strokes versus hemorrhagic strokes, and heart attack is the most common type of stroke in these patients. This fact is due to the multiple microvascular damages and the simultaneous presence of arterial hypertension in diabetic patients [5,6].
-
Diabetic patients have a greater functional disability, long-term hospitalization, and also a higher risk of dementia [7,8].
-
Multicenter studies have shown that approximately 20–33% of stroke patients have diabetes [9,10,11].
-
However, some studies suggest that diabetes has no influence on motor and functional outcomes within the acute and post-acute phase after stroke. Further research should be conducted to investigate motor recovery in a longer-term period and with larger samples.
In conclusion, the multidisciplinary approach that involves the diabetologist and neurologist in the case of a diabetic patient with a stroke is the key to success for a complete, functional, and integrated rehabilitation.

1.2. Scientometric Methods

Scientometric methods involve the quantitative analysis of the generation, dissemination, and use of scientific information, and allow the determination of large and emerging trends in scientific research in a particular field of research, based on statistical analysis of databases and the use of qualitative filters (topics, keywords, magazines). At the same time, it allows the review of the development of research over time or the geographical and organizational distribution of scientific production. The primary scientific data used for scientometric research are the authors, their papers, bibliographic references, and quotations received [12].
Scientometric examinations allow the identification of the most current research topics in a certain field, and the identification of the most quoted papers and authors who have addressed a specific topic. It is possible to determine which countries, institutions, and journals have the greatest influence on the development of science in a particular field and to analyze how the interest in a particular scientific discovery varies over time [13,14].
“A fast-growing trend is the increase of systematic reviews conducted with the assistance of science mapping tools” [13]. A science mapping tool typically takes a set of bibliographic records of a research field and generates an overview of the underlying knowledge domain, very quickly. “A scientometric overview of a field of research provides a valuable source of input to conducting systematic reviews, especially in situations when relevant and up-to-date systematic reviews may not be readily available or accessible” [14].

2. Materials and Methods

The Web of Science database was chosen as a representative sample of the scientific population in the field of diabetes and stroke. Using bibliographic data from this database, this paper seeks to identify current and future directions of research in the field of “diabetes” AND “stroke recovery”. In this respect, the search in the database was limited for the time period 2011–2021, the last 10 years. The works were searched by topic, respectively ((“diabetes” OR “diabetes mellitus” OR “type 2 diabetes” OR “type 1 diabetes”) AND “stroke recovery”). The search was performed on 28 May 2021, and the resulting works were refined according to the type of documents, and only the scientific articles, in English and in Open Access, were selected, resulting in 46 papers.
Primary data were downloaded as plain text files from the Web of Science (WoS) database. The results were examined using VOS Viewer software version 1.6.16 [15], which allows scientific mapping to analyze the content of titles and abstracts of scientific publications. Thus, the VOS Viewer term identification function was used to systematically identify key terms in the database (co-word analysis) and organize large amounts of text in a semantic map, ignoring the elements related to the structure of abstracts and copyright statements that might be included.
To prepare the terms for mapping purposes, VOS Viewer measures the link between the terms using the power measurement and suggests how many terms should be included in the map.
In this case, of the 1663 terms identified, 90 were used more than 2 times. The groups were analyzed, and the research directions were identified. In addition to this analysis, collaboration and quotation networks have been identified, details of which will be provided in the next section.
The scientometric study includes seven steps, according to Table 1, starting with the formulation of the problem, the establishment of protocols and research criteria, and the extraction of data, which were subsequently analyzed, synthesized, and discussed.
Analysis and interpretation of scientometric research data.
A total of 214 authors contributed to the writing of the 46 papers in the 10 years analyzed. The main authors are presented in Figure 1 according to the number of publications. There were 90 terms that appeared at least twice, and they are distributed in 6 clusters, according to Figure 2, Figure 3 and Figure 4.
Using the keyword list and Excel, the keyword figure was obtained (Figure 5).

3. Results

Following the review of the 46 papers, the authors identified 21 studies and articles reviewing the specific literature (Table 2). The articles were reviews, randomized studies, and meta-analyses. Some articles indicate the number of participants, while others do not, indicated as n for not specified in Table 2.
The authors have also reviewed the articles delimiting the research directions in the six clusters presented in Figure 2, Figure 3 and Figure 4. Table 3 summarizes the results.

4. Discussion

This article presented a new method of literature review, using scientometric methods. The method can be replicated by PhD students and researchers, in order to quickly obtain an image of any field researched. Studies in human models have shown that the therapeutic balance of diabetes is a very important factor in the rehabilitation of diabetic patients after stroke. The review of the articles and research directions led to conclusions that are important in the analysis of solutions for patients with diabetes and stroke. Articles studied in either animal or human models have highlighted several research directions for post-stroke rehabilitation programs.
The investigation of the articles led to different conclusions, which we present below in six directions of research.
  • Identification and possible modification of aggravating risk factors for stroke patients
Obesity associated with diabetes are factors that worsen the prognosis of recovery after stroke.
Ischemic strokes occur predominantly in diabetic patients with arrhythmias and acute coronary syndromes, while accidental hemorrhagic strokes occur predominantly in smokers and alcoholics [31].
2.
The influence of mental disorders on post-stroke recovery
Depression increases the risk of readmission to recovery centers and may contribute to dementia. A diabetic patient-centered recovery strategy alleviates the risk of depression and multiple post-stroke metabolic complications [16].
3.
Understanding post-stroke vascular remodeling processes
In young people, remodeling processes are active and long-lasting compared to the elderly, in whom remodeling is slowed down due to the presence of other comorbidities, such as diabetes, atherosclerosis, and dyslipidemia.
Glycemic variations in diabetics have negative effects on angiogenesis, so stimulating it in stroke patients is not currently an optimal solution for neurological recovery [29,54].
4.
The role of physical activity on post-stroke recovery
Information on this issue is still controversial. The indications for physical exercise in the early post-stroke phases showed progress in recovery, but neither their intensity nor their optimal duration was established. The lack of data in the literature indicates that early post-stroke mobilization is limited [32].
5.
The effects of drug therapies and dietary supplements
The effects of hypoglycemic medication on the risk of stroke are heterogeneous.
Sulfonylureas and metformin appear to have a potential protective effect in diabetic patients with hemorrhagic stroke [29].
Studies of DPP4 inhibitors in diabetic patients have shown a reduced risk of stroke. Complementary studies are needed to show possible effects of reducing brain damage in the case of stroke [19].
The use of long-term dietary supplements enriched with potassium and magnesium seems to be beneficial for post-stroke recovery, but the results require further studies to substantiate the indication [25].
The administration of micro-RNA biomarkers (miRNAs) in stroke therapy could be an alternative to long-term sequelae, but studies are still ongoing [21].
Another class of innovative antidiabetic drugs that inhibit SGLT2 with complex mechanisms of action do not increase the incidence of stroke. SGLT2 inhibitors produced a 50% decrease in hemorrhagic stroke compared to a placebo [55].
6.
There are a number of factors that can cause patients to drop out of rehabilitation programs. These are related to transportation problems to the recovery centers, long distances to reach these centers, boring exercises, lack of a companion, and limited time.
Therefore, future studies should focus on ways to overcome these barriers to encourage the participation of these patients in rehabilitation programs.

5. Conclusions

Following the scientometric research and the analysis of the specialized literature, the authors wish to raise the awareness of the specialists regarding the following aspects.
Proper management of diabetes and its many complications, including stroke neurology, requires the rapid identification of research results in different types of therapies and their effectiveness applied to various categories of patients.
The recovery of the diabetic patient after stroke after hemodynamic stabilization is the same as in the case of nondiabetic patients, but involves a longer period of time and has poorer results.
SGLT2 inhibitors had no effect on overall cerebrovascular events; however, results for stroke after using them vary depending on the kind of stroke, with a potential benefit for hemorrhagic stroke prevention. Further prospective trials comparing the effects of SGLT2 inhibitors on different stroke subtypes are needed.
Finally, we conclude that scientometric methods allow a rapid and efficient analysis of the research directions generated by scientific production in the field, making a decisive contribution to improving the approach to the disease and long-term treatments of patients with diabetes and stroke.

6. Limits of the Study

The scientometric analysis must be interpreted taking into account the limitations of the research. First, the results are limited to publications (articles and papers presented at conferences) published in 2011–2021 and indexed in the Web of Science database.
However, this scientometric analysis has allowed us to identify the main actors and research directions in the field in recent years. The results of the research show that many of the previous interests are still relevant today.

Author Contributions

Conceptualization, I.P., M.E.C. and A.R.; methodology, I.P., M.E.C. and A.R.; validation, I.P., M.E.C. and A.R.; formal analysis, I.P., M.E.C. and A.R.; writing—original draft preparation, A.R.; writing—review and editing, A.R.; visualization, A.R.; supervision, I.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Larkin, M.; Shaw, R.; Flowers, P. Multiperspectival designs and processes in interpretative phenomenological analysis research. Qual. Res. Psychol. 2019, 16, 182–198. [Google Scholar] [CrossRef]
  2. Siemkowicz, E.; Gjedde, A. Post-ischemic coma in rat: Effect of different pre-ischemic blood glucose levels on cerebral metabolic recovery after ischemia. Acta Physiol. Scand. 1980, 110, 225–232. [Google Scholar] [CrossRef] [PubMed]
  3. Sun, H.; Saeedi, P.; Karuranga, S.; Pinkepank, M.; Ogurtsova, K.; Duncan, B.B.; Stein, C.; Basit, A.; Chan, J.C.; Mbanya, J.C.; et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 2021, 183, 109119. [Google Scholar] [CrossRef] [PubMed]
  4. Zhu, S.; McClure, L.A.; Lau, H.; Romero, J.R.; White, C.L.; Babikian, V.; Nguyen, T.; Benavente, O.R.; Kase, C.S.; Pikula, A. Recurrent vascular events in lacunar stroke patients with metabolic syndrome and/or diabetes. Neurology 2015, 85, 935–941. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Vaidya, V.; Gangan, N.; Sheehan, J. Impact of cardiovascular complications among patients with Type 2 diabetes mellitus: A systematic review. Expert Rev. Pharm. Outcomes Res. 2015, 15, 487–497. [Google Scholar] [CrossRef]
  6. Hata, J.; Arima, H.; Rothwell, P.M.; Woodward, M.; Zoungas, S.; Anderson, C.; Patel, A.; Neal, B.; Glasziou, P.; Hamet, P.; et al. Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: The ADVANCE trial. Circulation 2013, 128, 1325–1334. [Google Scholar] [CrossRef] [Green Version]
  7. Shou, J.; Zhou, L.; Zhu, S.; Zhang, X. Diabetes is an Independent Risk Factor for Stroke Recurrence in Stroke Patients: A Meta-analysis. J. Stroke Cerebrovasc. Dis. 2015, 24, 1961–1968. [Google Scholar] [CrossRef]
  8. Capes, S.E.; Hunt, D.; Malmberg, K.; Pathak, P.; Gerstein, H.C. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview. Stroke 2001, 32, 2426–2432. [Google Scholar] [CrossRef] [Green Version]
  9. O’Donnell, M.J.; Chin, S.L.; Rangarajan, S.; Xavier, D.; Liu, L.; Zhang, H.; Rao-Melacini, P.; Zhang, X.; Pais, P.; Agapay, S.; et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): A case-control study. Lancet 2016, 388, 761–775. [Google Scholar] [CrossRef]
  10. Kernan, W.N.; Viscoli, C.M.; Inzucchi, S.E.; Brass, L.M.; Bravata, D.M.; Shulman, G.I.; McVeety, J.C. Prevalence of Abnormal Glucose Tolerance Following a Transient Ischemic Attack or Ischemic Stroke. Arch. Intern. Med. 2005, 165, 227. [Google Scholar] [CrossRef] [Green Version]
  11. Gray, C.S.; Scott, J.F.; French, J.M.; Alberti, K.G.M.M.; O’connell, J.E. Prevalence and prediction of unrecognised diabetes mellitus and impaired glucose tolerance following acute stroke. Age Ageing 2004, 33, 71–77. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Repanovici, A.; Rotaru, C.S.; Murzea, C. Development of Sustainable Thinking by Information Literacy. Sustainability 2021, 13, 1287. [Google Scholar] [CrossRef]
  13. Cobo, M.J.; López-Herrera, A.G.; Herrera-Viedma, E.; Herrera, F. Science mapping software tools: Review, analysis, and cooperative study among tools. J. Am. Soc. Inf. Sci. Technol. 2011, 62, 1382–1402. [Google Scholar] [CrossRef]
  14. Chen, C.; Song, M. Visualizing a field of research: A methodology of systematic scientometric reviews. PLoS ONE 2019, 14, e0223994. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. VOSviewer VOSviewer—Visualizing Scientific Landscapes. Available online: https://www.vosviewer.com// (accessed on 19 July 2021).
  16. Ouk, M.; Wu, C.-Y.; Colby-Milley, J.; Fang, J.; Zhou, L.; Shah, B.R.; Herrmann, N.; Lanctôt, K.L.; Linkewich, E.; Law, M.; et al. Depression and Diabetes Mellitus Multimorbidity Is Associated with Loss of Independence and Dementia Poststroke. Stroke 2020, 51, 3531–3540. [Google Scholar] [CrossRef] [PubMed]
  17. Marzolini, S.; Robertson, A.D.; Oh, P.; Goodman, J.M.; Corbett, D.; Du, X.; MacIntosh, B.J. Aerobic Training and Mobilization Early Post-stroke: Cautions and Considerations. Front. Neurol. 2019, 10, 1187. [Google Scholar] [CrossRef]
  18. Guo, S.; Som, A.T.; Arai, K.; Lo, E.H. Effects of angiotensin-II on brain endothelial cell permeability via PPARalpha regulation of para- and trans-cellular pathways. Brain Res. 2019, 1722, 146353. [Google Scholar] [CrossRef]
  19. Darsalia, V.; Johansen, O.E.; Lietzau, G.; Nyström, T.; Klein, T.; Patrone, C. Dipeptidyl Peptidase-4 Inhibitors for the Potential Treatment of Brain Disorders; A Mini-Review with Special Focus on Linagliptin and Stroke. Front. Neurol. 2019, 10, 493. [Google Scholar] [CrossRef] [Green Version]
  20. Falck, R.S.; Barha, C.K.; Chan, P.C.Y.; Liu-Ambrose, T. Refining sleep measurement using the Motionwatch8©: How many days of monitoring do we need to get reliable estimates of sleep quality for older adults with mild cognitive impairment? Sleep Sci. Pract. 2020, 4, 1–10. [Google Scholar] [CrossRef]
  21. Kim, E.; Yang, J.; Park, K.W.; Cho, S. Inhibition of VEGF Signaling Reduces Diabetes-Exacerbated Brain Swelling, but Not Infarct Size, in Large Cerebral Infarction in Mice. Transl. Stroke Res. 2017, 9, 540–548. [Google Scholar] [CrossRef]
  22. Abdalla, T.H.B.; Rutkofsky, I.H.; Syeda, J.N.; Saghir, Z.; Muhammad, A.S. Occupational Physical Activity in Young Adults and Stroke: Was It Due to My Job? Cureus 2018, 10, e3217. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Yu, X.; Song, R.; Jiaerken, Y.; Yuan, L.; Huang, P.; Lou, M.; Jiang, Q.; Zhang, M. White matter injury induced by diabetes in acute stroke is clinically relevant: A preliminary study. Diabetes Vasc. Dis. Res. 2016, 14, 40–46. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Tulsulkar, J.; Nada, S.E.; Slotterbeck, B.D.; McInerney, M.F.; Shah, Z.A. Obesity and hyperglycemia lead to impaired post-ischemic recovery after permanent ischemia in mice. Obesity 2016, 24, 417–423. [Google Scholar] [CrossRef] [PubMed]
  25. Pan, W.-H.; Lai, Y.-H.; Yeh, W.-T.; Chen, J.-R.; Jeng, J.-S.; Bai, C.-H.; Lin, R.-T.; Lee, T.-H.; Chang, K.-C.; Lin, H.-J.; et al. Intake of potassium- and magnesium-enriched salt improves functional outcome after stroke: A randomized, multicenter, double-blind controlled trial. Am. J. Clin. Nutr. 2017, 106, ajcn148536. [Google Scholar] [CrossRef] [Green Version]
  26. Wu, T.Y.; Campbell, B.C.; Strbian, D.; Yassi, N.; Putaala, J.; Tatlisumak, T.; Davis, S.M.; Meretoja, A.; on behalf of the VISTA-ICH Collaboration. Impact of pre-stroke sulphonylurea and metformin use on mortality of intracerebral haemorrhage. Eur. Stroke J. 2016, 1, 302–309. [Google Scholar] [CrossRef] [Green Version]
  27. Zhang, L.; Chopp, M.; Zhang, Y.; Xiong, Y.; Li, C.; Sadry, N.; Rhaleb, I.; Lu, M.; Zhang, Z.G. Diabetes Mellitus Impairs Cognitive Function in Middle-Aged Rats and Neurological Recovery in Middle-Aged Rats After Stroke. Stroke 2016, 47, 2112–2118. [Google Scholar] [CrossRef] [Green Version]
  28. Cao, K.-G.; Fu, C.-H.; Li, H.-Q.; Xin, X.-Y.; Gao, Y. A new prognostic scale for the early prediction of ischemic stroke recovery mainly based on traditional Chinese medicine symptoms and NIHSS score: A retrospective cohort study. BMC Complement. Altern. Med. 2015, 15, 407. [Google Scholar] [CrossRef] [Green Version]
  29. Ergul, A.; Abdelsaid, M.; Fouda, A.; Fagan, S.C. Cerebral Neovascularization in Diabetes: Implications for Stroke Recovery and beyond. J. Cereb. Blood Flow Metab. 2014, 34, 553–563. [Google Scholar] [CrossRef] [Green Version]
  30. Ivey, F.; Ryan, A. Resistive Training Improves Insulin Sensitivity after Stroke. J. Stroke Cerebrovasc. Dis. 2014, 23, 225–229. [Google Scholar] [CrossRef] [Green Version]
  31. Andersen, K.K.; Olsen, T.S.; Dehlendorff, C.; Kammersgaard, L.P. Hemorrhagic and ischemic strokes compared: Stroke severity, mortality, and risk factors. Stroke 2009, 40, 2068–2072. [Google Scholar] [CrossRef] [Green Version]
  32. Marzolini, S.; Balitsky, A.; Jagroop, D.; Corbett, D.; Brooks, D.; Grace, S.L.; Lawrence, D.; Oh, P. Factors Affecting Attendance at an Adapted Cardiac Rehabilitation Exercise Program for Individuals with Mobility Deficits Poststroke. J. Stroke Cerebrovasc. Dis. 2016, 25, 87–94. [Google Scholar] [CrossRef] [PubMed]
  33. Krinock, M.J.; Singhal, N.S. Diabetes, stroke, and neuroresilience: Looking beyond hyperglycemia. Ann. N. Y. Acad. Sci. 2021, 1495, 78–98. [Google Scholar] [CrossRef] [PubMed]
  34. Nannetti, L.; Paci, M.; Baccini, M.; Rinaldi, L.A.; Taiti, P.G. Recovery from stroke in patients with diabetes mellitus. J. Diabetes Its Complicat. 2009, 23, 249–254. [Google Scholar] [CrossRef] [PubMed]
  35. Tennant, K.A.; Brown, C.E. Diabetes Augments In Vivo Microvascular Blood Flow Dynamics after Stroke. J. Neurosci. 2013, 33, 19194–19204. [Google Scholar] [CrossRef] [Green Version]
  36. Prakash, R.; Li, W.; Qu, Z.; Johnson, M.A.; Fagan, S.C.; Ergul, A. Vascularization pattern after ischemic stroke is different in control versus diabetic rats relevance to stroke recovery. Stroke 2013, 44, 2875–2882. [Google Scholar] [CrossRef]
  37. Han, H.; Wu, L.-M.; Han, M.-X.; Yang, W.-M.; Wang, Y.-X.; Fang, Z.-H. Diabetes impairs spatial learning and memory and hippocampal neurogenesis via BDNF in rats with transient global ischemia. Brain Res. Bull. 2016, 124, 269–277. [Google Scholar] [CrossRef]
  38. Swardfager, W.; MacIntosh, B. Depression, Type 2 Diabetes, and Poststroke Cognitive Impairment. Neurorehabilit. Neural Repair 2016, 31, 48–55. [Google Scholar] [CrossRef] [Green Version]
  39. Sweetnam, D.; Holmes, A.; Tennant, K.A.; Zamani, A.; Walle, M.; Jones, P.; Wong, C.; Brown, C.E. Diabetes Impairs Cortical Plasticity and Functional Recovery Following Ischemic Stroke. J. Neurosci. 2012, 32, 5132–5143. [Google Scholar] [CrossRef] [Green Version]
  40. Pintana, H.; Lietzau, G.; Augestad, I.L.; Chiazza, F.; Nyström, T.; Patrone, C.; Darsalia, V. Obesity-induced type 2 diabetes impairs neurological recovery after stroke in correlation with decreased neurogenesis and persistent atrophy of parvalbumin-positive interneurons. Clin. Sci. 2019, 133, 1367–1386. [Google Scholar] [CrossRef] [Green Version]
  41. Reeson, P.; Tennant, K.A.; Gerrow, K.; Wang, J.; Novak, S.W.; Thompson, K.; Lockhart, K.-L.; Holmes, A.; Nahirney, P.C.; Brown, C.E. Delayed Inhibition of VEGF Signaling after Stroke Attenuates Blood-Brain Barrier Breakdown and Improves Functional Recovery in a Comorbidity-Dependent Manner. J. Neurosci. 2015, 35, 5128–5143. [Google Scholar] [CrossRef]
  42. Giaquintoi, S.; Ferrara, I.; Muscherà, R.; Pagano, G.; Nolfe, G. The effects of atrial flbrillation on functional recovery in post-stroke patients. Dissability Reabil. 2001, 23, 204–208. [Google Scholar]
  43. Kooperberg, C.; Cushman, M.; Hsia, J.; Robinson, J.G.; Aragaki, A.K.; Lynch, J.K.; Baird, A.E.; Johnson, K.C.; Kuller, L.H.; Beresford, S.A.; et al. Can biomarkers identify women at increased stroke risk? The Women’s Health Initiative hormone trials. PLoS Clin. Trials 2007, 2, e28. [Google Scholar] [CrossRef] [Green Version]
  44. Lee, J.; Reding, M. Effects of Thiazolidinediones on Stroke Recovery: A Case-Matched Controlled Study. Neurochem. Res. 2006, 32, 635–638. [Google Scholar] [CrossRef]
  45. Michael, K.M.; Shaughnessy, M. Stroke Prevention and Management in Older Adults. J. Cardiovasc. Nurs. 2006, 21, S21–S26. [Google Scholar] [CrossRef] [PubMed]
  46. Abdul, Y.; Abdelsaid, M.; Li, W.; Webb, R.C.; Sullivan, J.C.; Dong, G.; Ergul, A. Inhibition of Toll-Like Receptor-4 (TLR-4) Improves Neurobehavioral Outcomes After Acute Ischemic Stroke in Diabetic Rats: Possible Role of Vascular Endothelial TLR-4. Mol. Neurobiol. 2018, 56, 1607–1617. [Google Scholar] [CrossRef] [PubMed]
  47. Reeson, P.; Jeffery, A.; Brown, C.E. Illuminating the Effects of Stroke on the Diabetic Brain: Insights from Imaging Neural and Vascular Networks in Experimental Animal Models. Diabetes 2016, 65, 1779–1788. [Google Scholar] [CrossRef] [Green Version]
  48. Augestad, I.L.; Pintana, H.; Larsson, M.; Krizhanovskii, C.; Nyström, T.; Klein, T.; Darsalia, V.; Patrone, C. Regulation of Glycemia in the Recovery Phase After Stroke Counteracts the Detrimental Effect of Obesity-Induced Type 2 Diabetes on Neurological Recovery. Diabetes 2020, 69, 1961–1973. [Google Scholar] [CrossRef]
  49. Stinear, C.M.; Smith, M.-C.; Byblow, W.D. Prediction Tools for Stroke Rehabilitation. Stroke 2019, 50, 3314–3322. [Google Scholar] [CrossRef]
  50. Jackson-Cowan, L.; Eldahshan, W.; Dumanli, S.; Dong, G.; Jamil, S.; Abdul, Y.; Althomali, W.; Baban, B.; Fagan, S.; Ergul, A. Delayed Administration of Angiotensin Receptor (AT2R) Agonist C21 Improves Survival and Preserves Sensorimotor Outcomes in Female Diabetic Rats Post-Stroke through Modulation of Microglial Activation. Int. J. Mol. Sci. 2021, 22, 1356. [Google Scholar] [CrossRef]
  51. Khoshnam, S.E.; Winlow, W.; Farbood, Y.; Moghaddam, H.F.; Farzaneh, M. Emerging Roles of microRNAs in Ischemic Stroke: As Possible Therapeutic Agents. J. Stroke 2017, 19, 166–187. [Google Scholar] [CrossRef]
  52. Chelluboina, B.; Vemuganti, R. Chronic kidney disease in the pathogenesis of acute ischemic stroke. J. Cereb. Blood Flow Metab. 2019, 39, 1893–1905. [Google Scholar] [CrossRef] [PubMed]
  53. Soto-Cámara, R.; Trejo-Gabriel-Galán, J.M.; González-Bernal, J.; González-Santos, J.; Cubo, E. Factors associated with the activation of emergency medical services in patients with acute stroke: A prospective study. Emerg. Rev. Soc. Espanola Med. Emerg. 2019, 31, 86–90. [Google Scholar]
  54. Hermann, D.M.; Buga, A.-M.; Popa-Wagner, A. Neurovascular remodeling in the aged ischemic brain. J. Neural Transm. 2015, 122, 25–33. [Google Scholar] [CrossRef] [PubMed]
  55. Tsai, W.-H.; Chuang, S.-M.; Liu, S.-C.; Lee, C.-C.; Chien, M.-N.; Leung, C.-H.; Liu, S.-J.; Shih, H.-M. Effects of SGLT2 inhibitors on stroke and its subtypes in patients with type 2 diabetes: A systematic review and meta-analysis. Sci. Rep. 2021, 11, 15364. [Google Scholar] [CrossRef]
Figure 1. Authors, visual map according to number of publications.
Figure 1. Authors, visual map according to number of publications.
Healthcare 10 00773 g001
Figure 2. Keyword density map.
Figure 2. Keyword density map.
Healthcare 10 00773 g002
Figure 3. Keyword density map.
Figure 3. Keyword density map.
Healthcare 10 00773 g003
Figure 4. Keyword density map.
Figure 4. Keyword density map.
Healthcare 10 00773 g004
Figure 5. Keywords’ occurrence. The words that have the highest rate of occurrence are: neuropathy, disease, and type 2 diabetes mellitus. Epidemiology, diabetes mellitus, mortality, risk factors, peripheral neuropathy, prevalence, stroke, polyneuropathy.
Figure 5. Keywords’ occurrence. The words that have the highest rate of occurrence are: neuropathy, disease, and type 2 diabetes mellitus. Epidemiology, diabetes mellitus, mortality, risk factors, peripheral neuropathy, prevalence, stroke, polyneuropathy.
Healthcare 10 00773 g005
Table 1. Scientometric study stages.
Table 1. Scientometric study stages.
No.StepsDescription
1Formulation of the problemMapping, bibliometric analysis of publications using descriptors and identification of research directions.
2Research criteriaSubject: ((“diabetes” OR “diabetes mellitus” OR “type 2 diabetes” OR “type 1 diabetes”) AND “stroke recovery”)
3Database used for researchClaryvate analytics, Web of Science (WoS)
Accessed on 28 May 2021
4Eligibility criteriaFilter 1: years of publication (2011–2020)
Result: 1663 documents
Filter 2: articles
Filter 3: English
Filter 4: Open Access
Result: 43 documents
5Data extractionBilingual format
6Analysis and synthesis of resultsQualitative (descriptive) and quantitative (bibliometric) using VOS Viewer
7DiscussionsAnalysis of the data gained
Table 2. Studies and reviews, literature articles. n = not specified.
Table 2. Studies and reviews, literature articles. n = not specified.
SourceNumber of ParticipantsTrial TypeDuration of the TrialTitle of the Study
[16]23,579Randomized trial2003–2013Depression and Diabetes Mellitus Multimorbidity is Associated with Loss of Independence and Dementia Post-Stroke
[17]46ReviewnAerobic Training and Mobilization Early Post-Stroke: Cautions and Consideration
[18]nReviewnEffects of Angiotensin-II on Brain Endothelial Cell Permeability via
PPAR-alpha Regulation of Para- and Trans-Cellular Pathways
[19]nReview2011–2019Dipeptidyl Peptidase-4 Inhibitors for the Potential Treatment of Brain Disorders: A Mini-Review with Special Focus on Linagliptin and Stroke
[20]70Randomized trial14 daysSleep and Cognitive Function in Chronic Stroke: A Comparative Cross-Sectional Study
[21]58,265Meta-analysisnCerebral Vascular Injury in Diabetic Ischemia and Reperfusion
[22]nReviewnOccupational Physical Activity in Young Adults and Stroke: Was It Due to My Job?
[21]nArticlenImpact of microRNAs on Ischemic Stroke: From Pre- to Post-Disease
[23]160TrialApril–June 2014Increased Expression of STIM1/Orai1 in Platelets of Stroke Patients Predictive of Poor Outcomes
[24]nArticlenStroke in Women: Risk Factors and Clinical Biomarkers
[25]291Study2009–2013Intake of Potassium- and Magnesium-Enriched Salt Improves Functional
Outcome after Stroke: A Randomized, Multicenter, Double-Blind Controlled Trial
[26]374StudyJanuary 2005–May 2010Clinical and Imaging Correlates of Outcome after Intracerebral Hemorrhage
[27]78Clinical
trial
12 weeksRationale and Design to Assess the Efficacy and Safety of HT047 in Patients with Acute Ischemic Stroke: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase II Trial
[28]489Trial2004–2009A New Prognostic Scale for the Early Prediction of Ischemic Stroke Recovery Mainly Based on Traditional Chinese Medicine Symptoms and NIHSS Score: A Retrospective Cohort Study
[29]nReviewnCerebral Neovascularization in Diabetes: Implications for Stroke Recovery and Beyond
[30]10StudynResistive Training Improves Insulin Sensitivity after Stroke
Table 3. Diabetes and stroke research directions, determined by the six clusters.
Table 3. Diabetes and stroke research directions, determined by the six clusters.
ClusterConclusionsSupporting Document
1The post-stroke motor function is improved by physical activity due to low levels of epinephrine and norepinephrine.[22]
Resistive training can decrease post-stroke glucose metabolism and thus increase post-stroke survival.[29]
Age is an important factor in post-stroke recovery: patients under the age of 56 are more likely to recover than those over the age of 56. [27]
The combination of diabetes mellitus (DM) and high blood pressure (HBP) entails a poorer recovery in the first 3 days after the stroke.[27]
Patients with diabetes and heart disease are more likely to have a predominantly ischemic stroke, while smokers and alcoholics are more likely to have a hemorrhagic stroke.[31]
Mobilization of post-stroke patients in the first 6 h exacerbates injuries, whereas after 24 h from stroke the mobilization has beneficial effects.[32]
Late recovery in special centers encounters difficulties in transporting patients to these centers and thus the sequelae can no longer recover[32]
DM decreases the effectiveness of thrombolysis and increases the risk of post-trobotic hemorrhage. [33]
DM does not affect motor and functional recovery in the acute and post-acute phase of stroke.[34]
2DM impairs cortical plasticity.[35]
DM affects post-stroke neovascularization, thus preventing post-stroke recovery.[36]
Diabetes impairs spatial memory and hippocampal neurogenesis in ischemic stroke.[37]
Diabetes increases the risk of dementia by 85% compared to non-diabetic people.[16]
The association of dementia with diabetes in stroke patients leads to poorer results in post-stroke recovery.[38]
The recovery rate was slower in patients with stroke and diabetes. DM exacerbated anxiety and cognitive decline.[39]
DM highly increases neurovascular damage and thus depreciates post-stroke recovery.[37]
Obesity with diabetes determines reduced neurogenesis and impaired neuroplasticity after stroke.[40]
Obesity induces a reduced post-stroke recovery.[41]
Atrial fibrillation appears to affect post-stroke recovery.[42]
Gender-related: Women appear to be more likely to have a stroke than men.[43]
In the first 3 months after the stroke, mortality is higher in the event of hemorrhagic stroke.[31]
Intake of N acetyl seryl aspartyl lysyl proline (AcSDKP) has led to improved neurological functional recovery in rats with diabetes.[23]
Thiazolidinedione treatment in diabetic stroke patients has intensified post-stroke functional recovery by decreasing infarct volume and vasodilation.[44]
Long-term administration of potassium and magnesium benefits post-stroke recovery.[25]
Sulfonylureas and metformin used in hemorrhagic stroke causes angiogenesis and has a high safety profile.[37]
Metformin mediates post-stroke recovery by increasing angiogenesis.[29]
3In the elderly, 40% have moderate functional post-stroke impairment, but people over 85 show slower rehabilitation.[45]
Angiogenesis in diabetic patients is greatly slowed down.[46]
Glycemic control prevents the decline of neovascularization and post-stroke recovery.[29]
Type 1 diabetes has a 4–6 times higher incidence of ischemic stroke occurrence.[47]
Post-stroke blood–brain barrier dysfunction (BHE) plays an important role in limiting functional recovery in diabetic patients.[41]
Angiotensin-II is a significant factor in increasing endothelial permeability in the brain and contributes to angiogenesis and neurogenesis.[18]
4Effects of DM treatment on post-stroke recovery:
Antidiabetic medication such as DPP4 inhibitors, sulfonylurea. Glimepiride causes faster post-stroke recovery in obese diabetic patients.
[48,49]
DPP4 does not decrease the risk of stroke but causes early recovery and rehabilitation in the first 3 days after a stroke.[19]
Obesity and diabetes worsen post-stroke recovery, and these effects are counteracted by the administration of DPP4/sulfonylurea at 3 days post-stroke, leading to early recovery.[19,48]
Stroke shows an increased number of neurons 6 weeks after the stroke. Diabetes causes neuroplasticity and thus this effect of increasing the number of neurons is abolished.[48]
5Innovative therapies in animal studies.
Administration of C21 to a type 2 angiotensin-II receptor agonist on day 3 after a stroke resulted in a reduction in neuroinflammation in male animals with diabetes.
[50]
Inhibition of TOLL-4 (TLR4) receptors in microvascular endothelial cells would reduce inflammation and improve post-stroke recovery in diabetics.[46]
miRNA assay would be a biomarker for the diagnosis of stroke and the evaluation of the effectiveness of stroke treatment.[51]
6White matter lesions in the brain occur in diabetic patients long before stroke occurrence.[23]
Patients with chronic kidney disease (CKD) more frequently suffer ischemic stroke than hemorrhagic stroke.[52]
In patients with BCR, uremic toxins cross the BHE and are thus involved in cognitive dysfunction and neurodegeneration.[52]
In stroke patients, the combination of CKD worsens recovery and limits the choice of therapies for stroke treatment.[53,54]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Pantea, I.; Repanovici, A.; Cocuz, M.E. Analysis of Research Directions on the Rehabilitation of Patients with Stroke and Diabetes Using Scientometric Methods. Healthcare 2022, 10, 773. https://doi.org/10.3390/healthcare10050773

AMA Style

Pantea I, Repanovici A, Cocuz ME. Analysis of Research Directions on the Rehabilitation of Patients with Stroke and Diabetes Using Scientometric Methods. Healthcare. 2022; 10(5):773. https://doi.org/10.3390/healthcare10050773

Chicago/Turabian Style

Pantea, Ileana, Angela Repanovici, and Maria Elena Cocuz. 2022. "Analysis of Research Directions on the Rehabilitation of Patients with Stroke and Diabetes Using Scientometric Methods" Healthcare 10, no. 5: 773. https://doi.org/10.3390/healthcare10050773

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop